Determination of isoniazid acetylation patterns in tuberculosis patients receiving DOT therapy under the Revised National tuberculosis Control Program (RNTCP) in India

Isoniazid is the most commonly used drug for treatment of tuberculosis, and is administered individually or in combination with other drugs as standard first line therapy. Offsetting its efficacy, severe adverse effects, especially peripheral neuropathy and hepatotoxicity, are associated with isonia...

Descripción completa

Detalles Bibliográficos
Autores principales: Imam, Faisal, Sharma, Manju, Khayyam, Khalid Umer, Khan, Mohammad Rashid, Ali, Mohammad Daud, Qamar, Wajhul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292862/
https://www.ncbi.nlm.nih.gov/pubmed/32550793
http://dx.doi.org/10.1016/j.jsps.2020.04.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292862/
https://www.ncbi.nlm.nih.gov/pubmed/32550793
http://dx.doi.org/10.1016/j.jsps.2020.04.003

Ejemplares similares